Juxtapid and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Juxtapid (lomitapide mesylate), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Repatha, and have Low density lipoprotein.

The phase IV clinical study analyzes which people have Stroke when taking Juxtapid. It is created by eHealthMe based on reports of 4,275 people who have side effects when taking Juxtapid from the FDA, and is updated regularly.

What is Juxtapid?

Juxtapid has active ingredients of lomitapide mesylate. eHealthMe is studying from 4,279 Juxtapid users. Check the latest studies of Juxtapid.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,325 drugs and 3,028 conditions by eHealthMe. Check the latest studies of Stroke.

On Jun, 25, 2026

4,275 people reported to have side effects when taking Juxtapid.
Among them, 48 people (1.12%) have Stroke.

Among these 48 people:

How long have people been on Juxtapid when they have Stroke? *

What is the gender of people who have Stroke when taking Juxtapid? *

female: 24.32 %
male: 75.68 %

What is the age of people who have Stroke when taking Juxtapid? *

What are other drugs people take besides Juxtapid? *

Repatha: 32 people, 66.67%
Praluent: 30 people, 62.50%
Zocor: 28 people, 58.33%
Mevacor: 28 people, 58.33%
Lescol: 27 people, 56.25%
Lipitor: 27 people, 56.25%
Crestor: 13 people, 27.08%
Vascepa: 12 people, 25.00%
Ezetimibe: 9 people, 18.75%
Colesevelam Hydrochloride: 8 people, 16.67%

What are other side effects people have besides Stroke? *

Heart Attack: 32 people, 66.67%
Drug Ineffective: 30 people, 62.50%
Weight Decreased: 4 people, 8.33%
Diarrhea: 4 people, 8.33%
Nausea (feeling of having an urge to vomit): 4 people, 8.33%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 3 people, 6.25%
Small Intestinal Obstruction (blockage in small intestine): 3 people, 6.25%
Chest Pain: 3 people, 6.25%
Carotid Artery Occlusion (artery blockage): 2 people, 4.17%
Viral Infection: 2 people, 4.17%

What are the existing conditions these people have? *

Low Density Lipoprotein: 28 people, 58.33%
Low Density Lipoprotein Abnormal (cholesterol abnormal): 12 people, 25.00%
Diabetes: 3 people, 6.25%
Thyroid Diseases: 2 people, 4.17%
Dyslipidaemia (abnormal amount of lipids): 2 people, 4.17%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 4.17%
Arrhythmias (irregular heartbeat): 2 people, 4.17%
Nausea (feeling of having an urge to vomit): 1 person, 2.08%
Nasopharyngitis (inflammation of the nasopharynx): 1 person, 2.08%
Lipids Increased (excess lipid in body): 1 person, 2.08%

* Approximation only. Some reports may have incomplete information.

Do you take Juxtapid and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Juxtapid:

Juxtapid (4,279 reports)

Stroke treatments and more:

Stroke (334,635 reports)

Browse all side effects of Juxtapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,325 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,028 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lomitapide mesylate (the active ingredients of Juxtapid) and Juxtapid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.